The Global Multiple Drug Resistance (MDR) Bacterial Infection Treatment Market is gaining significant attention as antimicrobial resistance continues to threaten public health worldwide. MDR bacterial infections occur when bacteria evolve mechanisms to survive exposure to multiple antibiotics, making standard treatments less effective and leading to prolonged illness, increased healthcare...
According to a newly published market research report by 24LifeSciences, global head lice infestation treatment market was valued at USD 548.8 million in 2023 and is projected to reach USD 723.7 million by 2030, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period 2024–2030.
Head lice (Pediculus humanus capitis) are parasitic insects that infest human...
According to a newly published market research report by 24LifeSciences, global respiratory tract infection treatment market was valued at USD 9.8 billion in 2024 and is projected to reach USD 13.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 20252031.
Respiratory tract infections (RTIs) remain among the most common infectious diseases...
According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031.
Systemic infection treatments combat infections that have spread throughout the bloodstream...
NEWARK, DE – April 7, 2026 — The global uncomplicated urinary tract infection (UTI) treatment market is projected to grow from USD 7.7 billion in 2025 to USD 11.8 billion by 2035, registering a CAGR of 4.4% during the forecast period. The market expansion is primarily driven by rising infection prevalence, increasing awareness, improved diagnostic...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek